MEDTRONIC SURGICAL MECHANICAL VALVE
Report
- Report Number
- 2025587-2021-02927
- Event Type
- Injury
- Date Received
- September 30, 2021
- Date of Event
- February 10, 2021
- Report Date
- September 30, 2021
- Manufacturer
- MEDTRONIC HEART VALVES DIVISION
- Product Code
- LWQ
- PMA / PMN Number
- P790018
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- TU
- Reporter Occupation
- PHYSICIAN
Narratives
CITATION: SICIM H, ET AL. COMPARISON OF POSTOPERATIVE OUTCOMES BETWEEN ROBOTIC MITRAL VALVE REPLACEMENT AND CONVENTIONAL MITRAL VALVE REPLACEMENT. J CARD SURG. 2021 APR;36(4):1411-1418. DOI: 10.1111/JOCS.15418. EPUB 2021 FEB 10. EARLIEST DATE OF PUBLISH USED FOR DATE OF EVENT. MEDTRONIC PRODUCTS THAT MAY HAVE BEEN USED: MED HALL (PMA# P790018, PRODUCT CODE LWQ), OPEN PIVOT (PMA# P990046, PRODUCT CODE LWQ). EARLIEST APPROVED PRODUCT USED FOR PRODUCT CODE AND PMA#. NO UNIQUE DEVICE IDENTIFIER (SERIAL/LOT) NUMBERS WERE PROVIDED; WITHOUT THIS INFORMATION IT COULD NOT BE DETERMINED WHETHER THESE OBSERVATIONS HAVE BEEN PREVIOUSLY REPORTED. WITHOUT RETURN OF THE PRODUCT NO DEFINITIVE CONCLUSION CAN BE MADE REGARDING THE CLINICAL OBSERVATIONS. IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED.
MEDTRONIC RECEIVED INFORMATION FROM A LITERATURE ARTICLE REGARDING THE PATIENT OUTCOMES FOLLOWING ROBOTIC MITRAL VALVE REPLACEMENT COMPARED TO CONVENTIONAL STERNOTOMY. ALL DATA WAS RETROSPECTIVELY ANALYZED FROM A SINGLE CENTER BETWEEN 2014 AND 2020. THE STUDY POPULATION INCLUDED 130 PATIENTS (PREDOMINANTLY FEMALE, MEAN AGE 57.4 YEARS) WHO UNDERWENT ROBOTIC OR CONVENTIONAL MITRAL VALVE REPLACEMENT. THE AUTHORS WROTE, ¿ST. JUDE MEDICAL (MEDTRONIC) MECHANICAL HEART VALVES WERE USED FOR REPLACEMENT¿. SINCE ST. JUDE MEDICAL AND MEDTRONIC ARE TWO SEPARATE DEVICE MANUFACTURERS, IT IS UNKNOWN WHETHER ST. JUDE OR MEDTRONIC MECHANICAL HEART VALVES WERE IMPLANTED IN THE PATIENT POPULATION. NO BRAND NAMES OR UNIQUE DEVICE IDENTIFIER NUMBERS WERE DISCLOSED. AMONG ALL PATIENTS, FOUR POST-OPERATIVE DEATHS OCCURRED. NO STATEMENT WAS MADE SUGGESTING A CAUSAL OR CONTRIBUTORY RELATIONSHIP BETWEEN MEDTRONIC PRODUCT AND THE DEATHS. AMONG ALL PATIENTS, ADVERSE EVENTS THAT OCCURRED DURING THE POST-OPERATIVE PERIOD (BETWEEN THE IMPLANT PROCEDURE AND HOSPITAL DISCHARGE) INCLUDED: REVISION FOR BLEEDING; STROKE/NEUROLOGICAL COMPLICATIONS; WOUND INFECTION (SURGICAL INTERVENTION NOT REQUIRED); AND ARRHYTHMIA (RHYTHM RESTORED WITH MEDICATION OR CARDIOVERSION). MEDTRONIC PRODUCT MAY HAVE BEEN ASSOCIATED WITH THE ADVERSE EVENTS. NO ADDITIONAL ADVERSE PATIENT EFFECTS OR PRODUCT PERFORMANCE ISSUES WERE REPORTED.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1453210 | MEDTRONIC SURGICAL MECHANICAL VALVE | HEART-VALVE, MECHANICAL | LWQ | MEDTRONIC HEART VALVES DIVISION | MDT-MECH VALVE |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 57 YR | Life Threatening| R |